137 related articles for article (PubMed ID: 21042320)
41. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
42. Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies.
Bacher U; Haferlach C; Schnittger S; Kohlmann A; Kern W; Haferlach T
Ann Hematol; 2010 Jul; 89(7):643-52. PubMed ID: 20195608
[TBL] [Abstract][Full Text] [Related]
43. Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia.
Shih AH; Jiang Y; Meydan C; Shank K; Pandey S; Barreyro L; Antony-Debre I; Viale A; Socci N; Sun Y; Robertson A; Cavatore M; de Stanchina E; Hricik T; Rapaport F; Woods B; Wei C; Hatlen M; Baljevic M; Nimer SD; Tallman M; Paietta E; Cimmino L; Aifantis I; Steidl U; Mason C; Melnick A; Levine RL
Cancer Cell; 2015 Apr; 27(4):502-15. PubMed ID: 25873173
[TBL] [Abstract][Full Text] [Related]
44. [Significance of TET2 mutations in myeloid and lymphoid neoplasms].
Chiba S
Rinsho Ketsueki; 2016 Jun; 57(6):715-22. PubMed ID: 27384850
[TBL] [Abstract][Full Text] [Related]
45. Quantitative analysis of TEL/AML1 fusion transcripts by real-time RT-PCR assay in childhood acute lymphoblastic leukemia.
Ballerini P; Landman Parker J; Laurendeau I; Olivi M; Vidaud M; Adam M; Leverger G; Gerota I; Cayre YE; Bièche I
Leukemia; 2000 Aug; 14(8):1526-8. PubMed ID: 10942253
[No Abstract] [Full Text] [Related]
46.
Pasca S; Jurj A; Tomuleasa C; Zdrenghea M
Medicina (Kaunas); 2020 Nov; 56(12):. PubMed ID: 33255417
[No Abstract] [Full Text] [Related]
47. Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations.
Kurt H; Khoury JD; Medeiros LJ; Huh YO
Br J Haematol; 2018 May; 181(3):305. PubMed ID: 29411884
[No Abstract] [Full Text] [Related]
48. Frequency of ETV6/AML1 fusion in adult acute lymphoblastic leukemia.
Cuneo A; Agostini P; Vitale A; Foà R; Castoldi G
Leukemia; 2003 Feb; 17(2):476-7; author reply 477. PubMed ID: 12592356
[No Abstract] [Full Text] [Related]
49. Ten-eleven-translocation 2 (TET2) is downregulated in myelodysplastic syndromes.
Scopim-Ribeiro R; Machado-Neto JA; Campos Pde M; Silva CA; Favaro P; Lorand-Metze I; Costa FF; Saad ST; Traina F
Eur J Haematol; 2015 May; 94(5):413-8. PubMed ID: 25200248
[TBL] [Abstract][Full Text] [Related]
50. MLL partial tandem duplications in acute leukemia cell lines.
Quentmeier H; Reinhardt J; Zaborski M; Drexler HG
Leukemia; 2003 May; 17(5):980-1. PubMed ID: 12750714
[No Abstract] [Full Text] [Related]
51. Mutant DNMT3A in acute myeloid leukemia: guilty of inducing genetic instability?
Zebisch A; Hoefler G; Quehenberger F; Wölfler A; Sill H
Leukemia; 2013 Aug; 27(8):1777-8. PubMed ID: 23417030
[No Abstract] [Full Text] [Related]
52. [Genetic abnormalities associated with the relapse of childhood leukemia].
Yoshida K
Rinsho Ketsueki; 2016 Jul; 57(7):919-24. PubMed ID: 27498739
[TBL] [Abstract][Full Text] [Related]
53. GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.
Hellebostad M; Carpenter E; Hasle H; Mitchell C; Vyas P
J Pediatr Hematol Oncol; 2005 Jul; 27(7):408-9. PubMed ID: 16012335
[No Abstract] [Full Text] [Related]
54. Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.
Nibourel O; Kosmider O; Cheok M; Boissel N; Renneville A; Philippe N; Dombret H; Dreyfus F; Quesnel B; Geffroy S; Quentin S; Roche-Lestienne C; Cayuela JM; Roumier C; Fenaux P; Vainchenker W; Bernard OA; Soulier J; Fontenay M; Preudhomme C
Blood; 2010 Aug; 116(7):1132-5. PubMed ID: 20489055
[TBL] [Abstract][Full Text] [Related]
55. Infant leukaemia biology, aetiology and treatment.
Greaves MF
Leukemia; 1996 Feb; 10(2):372-7. PubMed ID: 8637251
[No Abstract] [Full Text] [Related]
56. Impact of TEL/AML1-positive patients on age distribution of childhood acute lymphoblastic leukemia in Czech Republic. Pediatric Hematology Working Group in Czech Republic.
Trka J; Zuna J; Hrusák O; Kalinová M; Muzíková K; Lauschman H; Starý J
Leukemia; 1998 Jun; 12(6):996-7. PubMed ID: 9639432
[No Abstract] [Full Text] [Related]
57. TET2 Mutation in Adult T-Cell Leukemia/Lymphoma.
Shimoda K; Shide K; Kameda T; Hidaka T; Kubuki Y; Kamiunten A; Sekine M; Akizuki K; Shimoda H; Yamaji T; Nakamura K; Abe H; Miike T; Iwakiri H; Tahara Y; Sueta M; Yamamoto S; Hasuike S; Nagata K; Kitanaka A
J Clin Exp Hematop; 2015; 55(3):145-9. PubMed ID: 26763362
[TBL] [Abstract][Full Text] [Related]
58. Deletion of TET2 gene in an acute myeloid leukemia case with a t(4;15)(q24;q26) characterized by glass needle based chromosome microdissection and oligonucleotide array.
Villa O; Mallo M; Kosyakova N; Salido M; Liehr T; Martínez-Avilés L; Pedro C; García-Aragonés M; Espinet B; Bellosillo B; Florensa L; Arenillas L; Cuscó I; Jurado LA; Solé F
Leuk Res; 2011 Sep; 35(9):e161-3. PubMed ID: 21684005
[No Abstract] [Full Text] [Related]
59. TET2 missense variants in human neoplasia. A proposal of structural and functional classification.
Bussaglia E; Antón R; Nomdedéu JF; Fuentes-Prior P
Mol Genet Genomic Med; 2019 Jul; 7(7):e00772. PubMed ID: 31187595
[TBL] [Abstract][Full Text] [Related]
60. Identification of various MLL gene aberrations that lead to MLL gene mutation in patients with acute lymphoblastic leukemia (ALL) and infants with acute leukemia.
Pais A; Amare Kadam P; Raje G; Sawant M; Kabre S; Jain H; Advani S; Banavali S
Leuk Res; 2005 May; 29(5):517-26. PubMed ID: 15755504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
